| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/19/2005 | US20050107583 Transport peptides for controlled delivery of substances into cells; drug delivery |
| 05/19/2005 | US20050107581 Steam stripping beads under vacuum; divinyl benzene/ethyl vinyl benzene copolymers; dilution; for production of cephalosporin C and insulin |
| 05/19/2005 | US20050107543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/19/2005 | US20050107446 Two components mixture comprising a powder of atorvastatin with an alkalizing agent that forms a pH greater than 5 and a second component without the alkalizing agent; treating angina pectoris, hypertension, atherosclerosis |
| 05/19/2005 | US20050107429 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/19/2005 | US20050107418 Macrolides |
| 05/19/2005 | US20050107330 Drug mixture contains a sympathomimetic selected from the group consisting oxymetazoline, xylometazoline, tramazoline, tetryzoline and naphazoline, and glycosaminoglycan of hyaluronic acid; synergistic effect; vasoconstrictor action, detumescent action on the nose mucous membrane |
| 05/19/2005 | US20050107302 Applying formulation containing ovalbumin containing a growth factor selected from epidermal growth factor, transforming growth factor alpha, fibroblast growth factors, phenoxyethanol, triethanolamine, carbomer for scar prevention |
| 05/19/2005 | US20050107297 Novel poly(ethylene glycol) modified compounds and uses thereof |
| 05/19/2005 | US20050107292 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 05/19/2005 | US20050107291 Compositions and methods for treating or preventing diseases of body passageways |
| 05/19/2005 | US20050107277 Polyalkylene polymer compounds and uses thereof |
| 05/19/2005 | US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 05/19/2005 | US20050106726 RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA) |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106657 Using fungal propagation and fermentation to generate carotenoids for use as food and pharmaceutical supplements |
| 05/19/2005 | US20050106620 Novel ovarian tumor antigen (OVR107) for use in diagnosis, prognosis, classification and imaging of cell proliferative disorders |
| 05/19/2005 | US20050106272 Co-beadlet of dha and rosemary and methods of use |
| 05/19/2005 | US20050106265 Preservative method |
| 05/19/2005 | US20050106255 Human tissue engineering, tissue replacement; joint replacement |
| 05/19/2005 | US20050106254 Method for preparing gels |
| 05/19/2005 | US20050106251 Zero order controlled drug delivery system |
| 05/19/2005 | US20050106245 Sustained release preparations and process for producing the same |
| 05/19/2005 | US20050106242 Enhanced dissolution and bioavailibilty of beneficial agents with low water solubility; homogenizing; capsules |
| 05/19/2005 | US20050106240 Composition for rapid disintegrating tablet in oral cavity |
| 05/19/2005 | US20050106239 Stabilized azithromycin compositions |
| 05/19/2005 | US20050106238 Orodispersible pharmaceutical composition comprising ivabradine |
| 05/19/2005 | US20050106237 Orodispersible pharmaceutical composition comprising perindopril |
| 05/19/2005 | US20050106236 5-Ht4partial agonist pharmaceutical compositions |
| 05/19/2005 | US20050106235 Nsaid formulation comprising a granular composition and an extra-granular composition |
| 05/19/2005 | US20050106234 Calcium formate for use as a dietary supplement |
| 05/19/2005 | US20050106233 Seamless; high oil content; formed by emulsion comprising oil, water, emulsifier (polyoxyethylene glycol-sorbitan monolaurate), water-soluble monovalent/polyvalent metal salt (calcium chloride), and acid; marmelo mucilage free; gelation |
| 05/19/2005 | US20050106231 Liposome-entrapped topoisomerase inhibitors |
| 05/19/2005 | US20050106228 Compositions for the treatment and prevention of cancer |
| 05/19/2005 | US20050106227 Transdermal drug delivery |
| 05/19/2005 | US20050106215 Food or pet food composition containing plant extract for bone health |
| 05/19/2005 | US20050106214 Excipients in drug delivery vehicles |
| 05/19/2005 | US20050106211 Fabrication of drug loaded biodegradable polymer fibers |
| 05/19/2005 | US20050106208 Elutable surface coating |
| 05/19/2005 | US20050106205 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners |
| 05/19/2005 | US20050106202 Endoparasiticidal gel composition |
| 05/19/2005 | US20050106191 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 05/19/2005 | US20050106189 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 05/19/2005 | US20050106186 Percutaneous preparations |
| 05/19/2005 | US20050106182 Rescue agents for treating botulinum toxin intoxications |
| 05/19/2005 | US20050106179 Isolated complexes of endotoxin and MD-2 |
| 05/19/2005 | US20050106157 Immunogenic formulations comprising oil bodies |
| 05/19/2005 | US20050106148 Method of treating blood disorders |
| 05/19/2005 | US20050106129 Method of obtaining immune cells from an animal |
| 05/19/2005 | US20050106122 Absorption enhancing agent |
| 05/19/2005 | US20050106120 Polyester containing active drugs and having amino acids in the main chain & comma; and its preparation method |
| 05/19/2005 | US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells |
| 05/19/2005 | US20050106105 Complex of annexin and ultrasonic contrast particles or polymer |
| 05/19/2005 | US20050106102 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 05/19/2005 | US20050106098 Microparticles and methods for their production |
| 05/19/2005 | US20050104247 Method for manufacture of films containing insoluble solids embedded in cellulose-based films |
| 05/19/2005 | DE10347940A1 Selbstemulgierende Zubereitungen A self preparations |
| 05/19/2005 | CA2586320A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 05/19/2005 | CA2545157A1 Disinfecting composition and methods of making and using same |
| 05/19/2005 | CA2544965A1 Heat moisture treated starch for the treatment of hypoglycaemia |
| 05/19/2005 | CA2544912A1 Methods of inhibiting the adherence of lenses to their packaging materials |
| 05/19/2005 | CA2544843A1 Chewable tablet |
| 05/19/2005 | CA2543940A1 Preparations for topical application and methods of delivering an active agent to a substrate |
| 05/19/2005 | CA2543485A1 Use of interferon-tau in medicine |
| 05/19/2005 | CA2543280A1 Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections |
| 05/19/2005 | CA2543030A1 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 05/19/2005 | CA2542527A1 Rna interferance mediated inhibition of cholinergic muscarinic receptor (chrm3) gene expression using short interfering nucleic acid /sina) |
| 05/19/2005 | CA2534995A1 The use of plp with peg-rmetase in vivo for enhanced efficacy |
| 05/18/2005 | EP1531168A1 Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure |
| 05/18/2005 | EP1530966A1 Process for the preparation of pharmaceutical suspensions for inhalation |
| 05/18/2005 | EP1530482A1 Use of urease for inhibiting cancer cell growth |
| 05/18/2005 | EP1530474A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 05/18/2005 | EP1530465A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 05/18/2005 | EP1530456A2 Non-vesicular cationic lipid formulations |
| 05/18/2005 | EP1530454A1 Use of diketopiperazine derivatives as photostable uv-filters in cosmetic and pharmaceutical preparations |
| 05/18/2005 | EP1389128A4 Method for inhibiting atherosclerotic plaque formation |
| 05/18/2005 | EP1186302B1 Ocular tension lowering composition for topical adminstration |
| 05/18/2005 | EP1063975B1 Crosslinkable macromers bearing initiator groups |
| 05/18/2005 | EP0839055B1 Modified methioninase, its use, recombinant host cells producing high levels of methioninase and method for purifying methioninase |
| 05/18/2005 | EP0830138B1 Use of fibroblast growth factor analogues to stimulate bone growth |
| 05/18/2005 | CN1617934A Improved method of producing lycopene, preparation for obtaining lycopene, and application thereof |
| 05/18/2005 | CN1617928A Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 05/18/2005 | CN1617926A A structure for presenting desired peptide sequences |
| 05/18/2005 | CN1617890A Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 05/18/2005 | CN1617833A Low water uptake silicas |
| 05/18/2005 | CN1617745A Stabilized formulations of adenovirus |
| 05/18/2005 | CN1617742A Methods for treating cancer by using tumor-derived dentrical cell inhibitory factor antagonist in combination with toll-like receptor agonist |
| 05/18/2005 | CN1617730A Compositions and methods for enhancing corticosteroid delivery |
| 05/18/2005 | CN1617723A Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 05/18/2005 | CN1617717A Pharmaceutical compositions of amlodipine and atorvastatin |
| 05/18/2005 | CN1617713A Ultrapure oral fludara formulation with a fast releasing active substance |
| 05/18/2005 | CN1617712A Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 05/18/2005 | CN1617711A Liposomal delivery of vitamin E based compounds |
| 05/18/2005 | CN1617710A Liposome composition for delivery of nucleic acid |
| 05/18/2005 | CN1617709A Stable topical formulation of clarithromycin |
| 05/18/2005 | CN1617708A Taste masked aqueous liquid pharmaceutical composition |
| 05/18/2005 | CN1617670A Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 05/18/2005 | CN1617667A Methods for preserving ophthalmic solutions and preserved ophtalmic solutions |
| 05/18/2005 | CN1616119A Method for injecting solid mater into hypodermis and its solid matter |
| 05/18/2005 | CN1616105A Medical coating powder containing nano material |